Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis C by EOB-MRI

Table 4 Analyses of liver-intervertebral disc ratio contributions to hepatocellular carcinoma occurrence risk divided by other risk factors

	Subgroup	n	Risk ratio	95%CI	P-value
Age	≥ 69	75	12.51	1.63-95.82	0.015
	< 69	67	9.2	1.11-76.58	0.041
Sex	Male	70	8.4	1.08-65.18	0.042
	Female	72	7.024	1.49-33.14	0.014
Platelet (× 103/μL)	< 120	67	4.48	1.01-19.89	0.048
	≥ 120	75	14.96	1.89-118.2	0.013
Albumin (g/dL)	< 4.2	72	9.7	1.27-74.24	0.029
	≥ 4.2	70	10.79	1.29-89.7	0.028
ALT ( U/L)	≥ 50	88	10.98	1.39-86.7	0.023
	< 50	54	12.7	1.62-99.63	0.016
IFN	-	103	13.35	1.78-100.1	0.011
	+	39	3.498	0.22-55.96	0.376
SVR	-	115	15.98	2.13-119.7	0.007
	+	27	3.795	0.28-60.74	0.346

ALT: Alanine aminotransferase; IFN: Interferon; SVR: Sustained virologic response.